Hints and tips:
Related Special Reports
...Bristol Myers Squibb trades on just seven times earnings while Pfizer is on 20 times. The frenzy for weight loss and diabetes medications is unlikely to fade....
...Mirati, which was purchased by Bristol Myers Squibb in a deal announced last year, did not immediately respond to a request for comment....
...Other drugmakers including Merck, Bristol Myers Squibb, and Johnson & Johnson, as well as the US pharmaceutical lobby group, have already filed lawsuits against the reforms....
...In the pharmaceutical industry, big companies including AstraZeneca, AbbVie and Bristol Myers Squibb have announced about $25bn worth of biotech-related deals....
...It follows similar lawsuits filed in recent weeks by Merck and Bristol Myers Squibb....
...Monday EU: European Central Bank vice-president Luis de Guindos speaking at the Investment Outlook conference, organised by Citi Private Bank, in Madrid UK: Zoopla House Price index, plus ICAEW Business...
...Myers Squibb; and a Novartis drug to treat heart failure called Entresto....
...Infrastructure experts say future British governments must therefore concentrate their limited financial firepower on regional growth hubs, where it can make the maximum difference....
...Carmignac has named Ardian’s Edouard Boscher as head of private equity, based in Paris....
...Results: Pharmaceutical companies Eli Lilly, Merck and Bristol Myers Squibb report results today, as do Southwest Airlines, Caterpillar and Honeywell....
...Only Vertu Motors, which is the owner of Bristol Street Motors, and Pendragon remain as large listed players....
...I realised that the percentage of people who had gone to state school was only 60 per cent at the University of Bristol when I was there, so 40 per cent private school, it’s almost 50/50, despite the fact...
...Howard Davis, founder of Bristol-based agency Howard Independent Estate Agent, said he had seen a shift in recent weeks, with a sell-off by private landlords pushing down average house prices in his area...
...The real problem, he says, is “unfettered private speculation and towers for the international super-rich”....
...Cancer, stroke and diabetes medications made by Merck, Johnson & Johnson and Bristol Myers Squibb are among the first tranche of medications selected for negotiation....
...One in Bristol complained that he had been asked to rule on which junction a child should be handed over on the M4 motorway....
...Last year, US drugmaker Bristol Myers Squibb said it could divert investment away from the UK because of the increasing clawbacks....
...Housing experts say many already are, but their ability to do so is limited by local as well as national factors....
...But brokers had limited resources to withstand several days of collateral illiquidity....
...The chief executive of Bristol Myers Squibb said last week he had a “significant concern” about the rising costs of a medicines levy, agreed between government and industry to cap the health service drugs...
...With only a single bar and a handful of chairs, The C&G has the feel of a private living room....
...His clients include employers across the private and public sectors, as well income-protection insurance providers....
...The conditions appear ripe for an M&A boom: big drugmakers are sitting on almost $300bn of cash and many, including Merck and Bristol-Myers-Squibb, need to refill their pipelines because of major patent...
International Edition